Diabetes Metab 101508 Schirra J, Nicolaus M, Woerle HJ, Struckmeier C, Katschinski M, Gke B (2009) GLP-1 regulates gastroduodenal motility involving cholinergic pathways
Efficacy and immune-related adverse event associations in avelumab-treated patients
Key Laboratory of Industrial Biotechnology, Ministry of Education, Southern Yangtze University, Wuxi, China 2
Programme architecture: three errors Three programme-design choices determine whether a country captures its share of the trillion
Studies have shown that reducing the content of FMO3 in insulin-resistant mice can inhibit FoxO1 (the central node of metabolic control), reduce the production of TMAO, and completely prevent the development of hyperglycemia, hyperlipidemia, and atherosclerosis (84)
That distinction is not pedantic